We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.31M
2
AMGN icon
Amgen
AMGN
+$1.97M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.79M
4
TSRO
TESARO, Inc.
TSRO
+$1.56M
5
CLX icon
Clorox
CLX
+$1.3M

Top Sells

1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFM icon
276
Sprouts Farmers Market
SFM
$7.13B
– –
-2,000
Closed -$46K
SJM icon
277
CALL
J.M. Smucker
SJM
$12B
– –
-10,000
Closed -$10K
SMH icon
278
PUT
VanEck Semiconductor ETF
SMH
$67.5B
– –
-20,000
Closed -$6K
SPY icon
279
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-30,000
Closed -$5K
STZ icon
280
Constellation Brands
STZ
$22.7B
– –
-2,418
Closed -$430K
TDG icon
281
TransDigm Group
TDG
$67.9B
– –
-2,458
Closed -$624K
TGTX icon
282
CALL
TG Therapeutics
TGTX
$8.4B
– –
-28,000
Closed -$7K
TGTX icon
283
PUT
TG Therapeutics
TGTX
$8.4B
– –
-47,700
Closed -$46K
TMUS icon
284
T-Mobile US
TMUS
$208B
– –
-1,300
Closed -$84K
TMUS icon
285
PUT
T-Mobile US
TMUS
$208B
– –
-22,000
Closed -$10K
TSN icon
286
CALL
Tyson Foods
TSN
$20.3B
– –
-40,600
Closed -$21K
TSN icon
287
Tyson Foods
TSN
$20.3B
– –
-14,788
Closed -$913K
TSN icon
288
PUT
Tyson Foods
TSN
$20.3B
– –
-82,500
Closed -$64K
UL icon
289
CALL
Unilever
UL
$134B
– –
-17,778
Closed -$50K
UL icon
290
PUT
Unilever
UL
$134B
– –
-4,444
Closed -$4K
ULTA icon
291
CALL
Ulta Beauty
ULTA
$20.6B
– –
-10,000
Closed -$135K
ULTA icon
292
Ulta Beauty
ULTA
$20.6B
– –
-1,000
Closed -$285K
ULTA icon
293
PUT
Ulta Beauty
ULTA
$20.6B
– –
-9,000
Closed -$47K
UTHR icon
294
United Therapeutics
UTHR
$22.7B
– –
-9,723
Closed -$1.32M
UTHR icon
295
PUT
United Therapeutics
UTHR
$22.7B
– –
-21,400
Closed -$77K
VEEV icon
296
PUT
Veeva Systems
VEEV
$31.7B
– –
-12,300
Closed -$1K
VRTX icon
297
Vertex Pharmaceuticals
VRTX
$123B
– –
-4,582
Closed -$552K
YELP icon
298
CALL
Yelp
YELP
$1.44B
– –
-77,100
Closed -$39K
YELP icon
299
PUT
Yelp
YELP
$1.44B
– –
-5,000
Closed -$19K
LUMO
300
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-3,278
Closed -$218K
10 11
12
13 14

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.